Does TACROLIMUS Cause Drug ineffective for unapproved indication? 1,050 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,050 reports of Drug ineffective for unapproved indication have been filed in association with TACROLIMUS (Tacrolimus). This represents 1.2% of all adverse event reports for TACROLIMUS.
1,050
Reports of Drug ineffective for unapproved indication with TACROLIMUS
1.2%
of all TACROLIMUS reports
184
Deaths
316
Hospitalizations
How Dangerous Is Drug ineffective for unapproved indication From TACROLIMUS?
Of the 1,050 reports, 184 (17.5%) resulted in death, 316 (30.1%) required hospitalization, and 80 (7.6%) were considered life-threatening.
Is Drug ineffective for unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 1,050 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Drug ineffective for unapproved indication?
GABAPENTIN (5,231)
METHOTREXATE (2,513)
DICLOFENAC (2,154)
RITUXIMAB (1,776)
LIDOCAINE (1,761)
METHYLPREDNISOLONE (1,750)
PREDNISONE (1,598)
MYCOPHENOLATE MOFETIL (1,596)
HUMAN IMMUNOGLOBULIN G (1,527)
DEXAMETHASONE (1,302)
Which TACROLIMUS Alternatives Have Lower Drug ineffective for unapproved indication Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB